Toxic interactions of Romiplostim and Rituximab in normal and thrombocytopenic Rats
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immunologic destruction of normal platelets and insufficient production of platelets mediated by autoantibodies. And there are different treatment options for management of thrombocytopenia according to each case. Because of th...
Saved in:
Main Authors: | Saeed H., Sayed H.M., Ramadan A., Nahla S. Kotb |
---|---|
Format: | article |
Language: | EN |
Published: |
Egyptian Society for Animal Management
2020
|
Subjects: | |
Online Access: | https://dx.doi.org/10.21608/javs.2019.20470.1000 https://doaj.org/article/40c8ab91f9484ff08280bb1be8c50ce7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures
by: Robert Flisiak, et al.
Published: (2021) -
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
by: Snigdha Nutalapati, et al.
Published: (2021) -
First report on health-related quality of life among children with chronic immune thrombocytopenia in Vietnam
by: Sang Ngoc Nguyen, PhD, et al.
Published: (2021) -
The pathophysiology of thrombocytopenia in chronic liver disease
by: Mitchell O, et al.
Published: (2016) -
Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline
by: Wobke E. M. van Dijk, et al.
Published: (2021)